Videos

Cian McCarthy, MD, cardiovascular fellow, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin. However, he expects that to rise because of high sensitivity troponin (hs-cTn) being included in recent guidelines as a front-line test.

VIDEO: High sensitivity cardiac troponin use based on the NCDR Chest Pain-MI Registry 

Cian McCarthy, MD, Massachusetts General Hospital, and a member of the National Cardiovascular Data Registry (NCDR) Chest Pain-MI registry steering committee, explains a study of the NCDR data showing only 33% of hospitals are using high-sensitivity troponin.

VIDEO: Meet the radiologist who’s in the hunt for NFL Fan of the Year

Breast-imaging specialist Amy Patel, MD, has already been named Fan No. 1 by her hometown Kansas City Chiefs. Now she’s up against national championship finalists from the NFL’s 31 other teams.

Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker. 

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients. 

Late-breaking cardiovascular study presentation at AHA 2022. #AHA22

VIDEO: Key takeaways from AHA 2022

Manesh R. Patel, MD, chair of AHA Scientific Sessions program, explains what he saw as the top takeaways from AHA 2022.

ACC President Ed Fry, MD, an interventional and general cardiologist at Ascension St. Vincent Hospital in Indianapolis, Indiana, and chair of the Ascension National Cardiovascular Service Line, says Medicare cuts for 2023 are a tipping point that need to be a call to action across medicine. #AHA22 #ACC

VIDEO: ACC president says Medicare cuts should be a call to action across healthcare

American College of Cardiology President Edward Fry, MD, spoke about recent Medicare cuts at the American Heart Association Scientific Sessions conference in Chicago. 

VIDEO: The many benefits of spectral CT for cardiovascular imaging

Suhny Abbara, MD, editor of Radiology: Cardiothoracic Imaging and chief of cardiothoracic imaging for University of Texas Southwestern Medical Center, discusses how spectral computed tomography (CT) can help both cardiac and general CT imaging.

MRI system advances include helium-free MRI systems (left is Philips version of this system), and compressed sensing (right, GE's version of this technology), which can greatly reduce scan times. Both technologies were mentioned in an overview by Signet Research of new tech that will be at RSNA 2022.

VIDEO: Overview of MRI market and technology trends

Bhvita Jani, research manager, Signify Research, explains some key trends and technology advances in the magnetic resonance imaging (MRI) market leading into the Radiological Society of North America (RSNA) 2022 meeting.